Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macropodidae | 1 | 2024 | 2 | 0.880 |
Why?
|
| Finite Element Analysis | 1 | 2024 | 5 | 0.880 |
Why?
|
| Noise | 4 | 2008 | 31 | 0.840 |
Why?
|
| Voice | 3 | 2008 | 6 | 0.810 |
Why?
|
| Chytridiomycota | 4 | 2011 | 4 | 0.810 |
Why?
|
| Sigmodontinae | 6 | 2024 | 12 | 0.800 |
Why?
|
| Bufonidae | 3 | 2011 | 3 | 0.760 |
Why?
|
| Pneumothorax | 1 | 2020 | 22 | 0.650 |
Why?
|
| Bronchoscopy | 1 | 2020 | 34 | 0.640 |
Why?
|
| Glottis | 4 | 2009 | 4 | 0.620 |
Why?
|
| Biopsy | 1 | 2020 | 228 | 0.610 |
Why?
|
| Models, Biological | 7 | 2009 | 1007 | 0.580 |
Why?
|
| Cystic Fibrosis | 4 | 2023 | 98 | 0.560 |
Why?
|
| Speech, Alaryngeal | 2 | 2008 | 3 | 0.550 |
Why?
|
| Hybridization, Genetic | 3 | 2024 | 14 | 0.480 |
Why?
|
| Selection, Genetic | 2 | 2013 | 73 | 0.370 |
Why?
|
| Climate Change | 2 | 2024 | 12 | 0.370 |
Why?
|
| Speech Acoustics | 3 | 2009 | 8 | 0.350 |
Why?
|
| Water | 2 | 2016 | 281 | 0.340 |
Why?
|
| Mating Preference, Animal | 2 | 2024 | 3 | 0.330 |
Why?
|
| Temperature | 1 | 2011 | 272 | 0.330 |
Why?
|
| Dermatomycoses | 1 | 2009 | 9 | 0.310 |
Why?
|
| Biological Evolution | 2 | 2007 | 102 | 0.300 |
Why?
|
| Phenotype | 2 | 2007 | 823 | 0.270 |
Why?
|
| Voice Quality | 1 | 2006 | 3 | 0.260 |
Why?
|
| Phylogeny | 1 | 2007 | 307 | 0.260 |
Why?
|
| Voice Disorders | 1 | 2006 | 2 | 0.250 |
Why?
|
| Animals | 14 | 2024 | 16893 | 0.240 |
Why?
|
| Severity of Illness Index | 3 | 2023 | 832 | 0.220 |
Why?
|
| Ankle | 1 | 2024 | 20 | 0.220 |
Why?
|
| Genetic Variation | 2 | 2003 | 269 | 0.220 |
Why?
|
| Stress, Mechanical | 1 | 2024 | 88 | 0.210 |
Why?
|
| Restless Legs Syndrome | 1 | 2023 | 3 | 0.210 |
Why?
|
| Perchlorates | 1 | 2023 | 8 | 0.210 |
Why?
|
| Locomotion | 1 | 2024 | 99 | 0.210 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 224 | 0.200 |
Why?
|
| Gait | 1 | 2024 | 101 | 0.200 |
Why?
|
| Hordeum | 1 | 2002 | 3 | 0.200 |
Why?
|
| Plant Leaves | 1 | 2002 | 16 | 0.200 |
Why?
|
| Anura | 1 | 2002 | 8 | 0.190 |
Why?
|
| Fungi | 1 | 2002 | 45 | 0.190 |
Why?
|
| Polymers | 2 | 2023 | 279 | 0.190 |
Why?
|
| Plant Proteins | 1 | 2002 | 85 | 0.180 |
Why?
|
| Optogenetics | 1 | 2021 | 23 | 0.180 |
Why?
|
| Male | 13 | 2024 | 18271 | 0.180 |
Why?
|
| Time Factors | 4 | 2020 | 2422 | 0.180 |
Why?
|
| Reproductive Isolation | 2 | 2024 | 4 | 0.160 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 35 | 0.160 |
Why?
|
| California | 4 | 2017 | 75 | 0.160 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 48 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 66 | 0.160 |
Why?
|
| Lung | 2 | 2020 | 456 | 0.150 |
Why?
|
| Calcium | 1 | 2021 | 497 | 0.150 |
Why?
|
| Humans | 15 | 2023 | 40217 | 0.140 |
Why?
|
| Species Specificity | 3 | 2015 | 273 | 0.140 |
Why?
|
| Disease Progression | 1 | 2020 | 541 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 1 | 2017 | 15 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2020 | 202 | 0.140 |
Why?
|
| Analysis of Variance | 2 | 2009 | 450 | 0.140 |
Why?
|
| Quinolones | 1 | 2017 | 20 | 0.140 |
Why?
|
| Adult | 5 | 2023 | 10255 | 0.130 |
Why?
|
| Body Size | 3 | 2017 | 15 | 0.130 |
Why?
|
| Sound Spectrography | 2 | 2006 | 10 | 0.130 |
Why?
|
| Longevity | 1 | 2017 | 95 | 0.130 |
Why?
|
| Ecosystem | 3 | 2013 | 28 | 0.130 |
Why?
|
| Speech Production Measurement | 2 | 2006 | 7 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 28 | 0.130 |
Why?
|
| Sebum | 1 | 2016 | 1 | 0.120 |
Why?
|
| Dermatoglyphics | 1 | 2016 | 2 | 0.120 |
Why?
|
| Female | 12 | 2024 | 20392 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 663 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2017 | 237 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 304 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2017 | 289 | 0.120 |
Why?
|
| Cestode Infections | 1 | 2015 | 1 | 0.120 |
Why?
|
| Protozoan Infections, Animal | 1 | 2015 | 2 | 0.120 |
Why?
|
| Rodent Diseases | 1 | 2015 | 4 | 0.120 |
Why?
|
| Nematode Infections | 1 | 2015 | 10 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2016 | 172 | 0.110 |
Why?
|
| Hydrogels | 1 | 2016 | 83 | 0.110 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 244 | 0.110 |
Why?
|
| Gene Flow | 1 | 2013 | 6 | 0.110 |
Why?
|
| Genetic Speciation | 1 | 2013 | 5 | 0.110 |
Why?
|
| Lipids | 1 | 2016 | 266 | 0.100 |
Why?
|
| Macrophages | 1 | 2017 | 888 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 2 | 2011 | 207 | 0.090 |
Why?
|
| Kidney | 1 | 2012 | 275 | 0.080 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2010 | 7 | 0.080 |
Why?
|
| Mycoses | 1 | 2010 | 36 | 0.080 |
Why?
|
| Phonation | 1 | 2009 | 2 | 0.080 |
Why?
|
| Wyoming | 1 | 2009 | 2 | 0.080 |
Why?
|
| Colorado | 1 | 2009 | 18 | 0.080 |
Why?
|
| Water Microbiology | 1 | 2009 | 10 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2009 | 197 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 470 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 463 | 0.070 |
Why?
|
| Geography | 1 | 2007 | 25 | 0.070 |
Why?
|
| Demography | 1 | 2007 | 128 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2009 | 345 | 0.070 |
Why?
|
| Vocal Cords | 1 | 2007 | 2 | 0.070 |
Why?
|
| Prevalence | 2 | 2023 | 870 | 0.070 |
Why?
|
| Loudness Perception | 1 | 2006 | 2 | 0.070 |
Why?
|
| Fourier Analysis | 1 | 2006 | 15 | 0.070 |
Why?
|
| Speech | 1 | 2007 | 38 | 0.060 |
Why?
|
| Phonetics | 1 | 2006 | 26 | 0.060 |
Why?
|
| Reproduction | 1 | 2024 | 80 | 0.050 |
Why?
|
| Anions | 1 | 2023 | 29 | 0.050 |
Why?
|
| Amphibians | 1 | 2003 | 4 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2003 | 33 | 0.050 |
Why?
|
| beta-Glucosidase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Glucan 1,3-beta-Glucosidase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Chitinases | 1 | 2002 | 10 | 0.050 |
Why?
|
| Algorithms | 1 | 2006 | 673 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2003 | 1766 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 24 | 0.050 |
Why?
|
| Sweetening Agents | 1 | 2002 | 18 | 0.050 |
Why?
|
| Influenza Vaccines | 1 | 2003 | 71 | 0.050 |
Why?
|
| Population Density | 1 | 2002 | 10 | 0.050 |
Why?
|
| North Carolina | 1 | 2002 | 39 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 101 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2002 | 89 | 0.050 |
Why?
|
| Perceptual Disorders | 1 | 2002 | 3 | 0.050 |
Why?
|
| Kinesthesis | 1 | 2002 | 4 | 0.050 |
Why?
|
| Glucans | 1 | 2002 | 65 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 14 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 330 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 248 | 0.050 |
Why?
|
| Orientation | 1 | 2002 | 22 | 0.050 |
Why?
|
| Cell Wall | 1 | 2002 | 113 | 0.050 |
Why?
|
| Photoreceptor Cells | 1 | 2021 | 19 | 0.050 |
Why?
|
| Primates | 1 | 2021 | 38 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2002 | 350 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2003 | 161 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 91 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2002 | 127 | 0.040 |
Why?
|
| Retina | 1 | 2021 | 92 | 0.040 |
Why?
|
| Attention | 1 | 2002 | 106 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2003 | 344 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 36 | 0.040 |
Why?
|
| Aged | 3 | 2008 | 8182 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 1416 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 133 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2017 | 9 | 0.040 |
Why?
|
| Seasons | 1 | 2017 | 112 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 197 | 0.030 |
Why?
|
| Middle Aged | 2 | 2008 | 10090 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 185 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 10 | 0.030 |
Why?
|
| Plasma Gases | 1 | 2016 | 5 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 539 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2016 | 79 | 0.030 |
Why?
|
| Wettability | 1 | 2016 | 8 | 0.030 |
Why?
|
| Electrodes | 1 | 2016 | 20 | 0.030 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2016 | 12 | 0.030 |
Why?
|
| Salts | 1 | 2016 | 15 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2016 | 28 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 26 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2016 | 49 | 0.030 |
Why?
|
| Touch | 1 | 2016 | 18 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1479 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 94 | 0.030 |
Why?
|
| Rheology | 1 | 2016 | 62 | 0.030 |
Why?
|
| Biomimetic Materials | 1 | 2016 | 32 | 0.030 |
Why?
|
| Cestoda | 1 | 2015 | 1 | 0.030 |
Why?
|
| Eimeria | 1 | 2015 | 1 | 0.030 |
Why?
|
| Giardia | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cryptosporidium | 1 | 2015 | 5 | 0.030 |
Why?
|
| Surface Properties | 1 | 2016 | 256 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 141 | 0.030 |
Why?
|
| Nematoda | 1 | 2015 | 32 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 408 | 0.030 |
Why?
|
| Inbreeding | 1 | 2013 | 4 | 0.030 |
Why?
|
| Chimera | 1 | 2013 | 36 | 0.030 |
Why?
|
| Courtship | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 1697 | 0.030 |
Why?
|
| Fertility | 1 | 2013 | 64 | 0.030 |
Why?
|
| Social Behavior | 1 | 2013 | 64 | 0.030 |
Why?
|
| Aggression | 1 | 2013 | 55 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 1055 | 0.020 |
Why?
|
| Tobramycin | 1 | 2012 | 7 | 0.020 |
Why?
|
| Time | 1 | 2012 | 18 | 0.020 |
Why?
|
| Colistin | 1 | 2012 | 5 | 0.020 |
Why?
|
| Gentamicins | 1 | 2012 | 15 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 37 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 89 | 0.020 |
Why?
|
| Sodium | 1 | 2010 | 37 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 78 | 0.020 |
Why?
|
| Ions | 1 | 2010 | 50 | 0.020 |
Why?
|
| Potassium | 1 | 2010 | 80 | 0.020 |
Why?
|
| Air Pressure | 1 | 2009 | 1 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 131 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 8809 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 3138 | 0.010 |
Why?
|
| Immunity, Active | 1 | 2003 | 7 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 2003 | 55 | 0.010 |
Why?
|
| Saliva | 1 | 2003 | 80 | 0.010 |
Why?
|
| Animal Diseases | 1 | 2003 | 1 | 0.010 |
Why?
|
| Reproduction, Asexual | 1 | 2003 | 3 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 81 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 95 | 0.010 |
Why?
|
| Nucleotides | 1 | 2003 | 35 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 2003 | 35 | 0.010 |
Why?
|
| Heterozygote | 1 | 2003 | 123 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 148 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2003 | 158 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 2002 | 26 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2002 | 117 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2002 | 231 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 183 | 0.010 |
Why?
|
| Stroke | 1 | 2002 | 731 | 0.010 |
Why?
|
| United States | 1 | 2003 | 4886 | 0.010 |
Why?
|